Document Detail


Intensive voice treatment in Parkinson's disease: Lee Silverman Voice Treatment.
MedLine Citation:
PMID:  21651330     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Advances in neuroscience have led to an expanded and improved understanding of neurobiological changes associated with rehabilitation and exercise in Parkinson's disease (PD). This knowledge has led to a direct clinical impact of increased referral for early and continuous exercise programs for individuals with PD (physical, occupational, speech therapy and general exercise programs) and an increased research focus on the impact of such approaches in humans with PD. The purpose of this article is to examine the role of speech therapy in the landscape of exercise-based interventions for individuals with PD. We will specifically focus on the intensive voice treatment protocol, Lee Silverman Voice Treatment, as an example therapy. This article will briefly review the literature on the characteristics and features of speech and voice disorders in individuals with PD, and will discuss the impact of pharmacological and surgical treatment techniques on these disorders. This will be followed by a focus on behavioral speech treatment, specifically Lee Silverman Voice Treatment, including development of the treatment approach, documenting efficacy, discovery of unexpected outcomes and insights into the mechanism of speech disorders in PD gained from treatment-related changes. This research will be placed in the context of other previous and current speech treatment approaches in development for individuals with PD, and will highlight future directions for research.
Authors:
Shimon Sapir; Lorraine O Ramig; Cynthia M Fox
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Expert review of neurotherapeutics     Volume:  11     ISSN:  1744-8360     ISO Abbreviation:  Expert Rev Neurother     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-06-09     Completed Date:  2011-10-20     Revised Date:  2014-09-13    
Medline Journal Info:
Nlm Unique ID:  101129944     Medline TA:  Expert Rev Neurother     Country:  England    
Other Details:
Languages:  eng     Pagination:  815-30     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Parkinson Disease / complications,  rehabilitation*
Speech Disorders / etiology,  rehabilitation*
Speech Therapy / methods*
Voice / physiology
Voice Disorders / etiology,  rehabilitation*
Voice Training*
Grant Support
ID/Acronym/Agency:
R01 DC001150/DC/NIDCD NIH HHS; R01 DC1150/DC/NIDCD NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pathological gambling in Parkinson's disease: disease related or drug related?
Next Document:  Cell-based therapies for Parkinson's disease.